Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neurofibroma, Plexiform 3Neurofibromatosis 1 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Radiation Fibrosis Syndrome 1Precancerous Conditions 1Pneumonia 1Neurofibromatoses 1Nerve Sheath Neoplasms 1Neoplasms 1Myofibroma 1Lymphedema 1Leiomyoma 1Colorectal Neoplasms 1Acute Lung Injury 1

Interventions

Losartan 3Radiotherapy 2pirfenidone 1Therapeutics 1Surgical Procedures, Operative 1Low-Level Light Therapy 1Hyperbaric Oxygenation 1Grape Seed Proanthocyanidins 1Exercise Test 1Esophagectomy 1Drug Therapy 1Captopril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Fibrosis Syndrome × pirfenidone × Clear all
NCT00020631 2013-06-19

Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer

National Cancer Institute (NCI)

Phase NA Completed

Radiation Fibrosis Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡